These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26040050)

  • 1. Current solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Raziel A; Sakran N; Szold A; Goitein D
    Isr Med Assoc J; 2015 Apr; 17(4):234-8. PubMed ID: 26040050
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical approach to non-alcoholic fatty liver disease in patients with diabetes.
    Tai FW; Syn WK; Alazawi W
    Diabet Med; 2015 Sep; 32(9):1121-33. PubMed ID: 25683343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.
    Mann JP; Goonetilleke R; McKiernan P
    Arch Dis Child; 2015 Jul; 100(7):673-7. PubMed ID: 25633064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
    Chitturi S; Wong VW; Chan WK; Wong GL; Wong SK; Sollano J; Ni YH; Liu CJ; Lin YC; Lesmana LA; Kim SU; Hashimoto E; Hamaguchi M; Goh KL; Fan J; Duseja A; Dan YY; Chawla Y; Farrell G; Chan HL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):86-98. PubMed ID: 28692197
    [No Abstract]   [Full Text] [Related]  

  • 5. Current and future treatment options in non-alcoholic steatohepatitis (NASH).
    Lazaridis N; Tsochatzis E
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):357-369. PubMed ID: 28276821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric Non-alcoholic Fatty Liver Disease.
    Uppal V; Mansoor S; Furuya KN
    Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery.
    Selby LV; Ejaz A; Brethauer SA; Pawlik TM
    Expert Opin Investig Drugs; 2020 Feb; 29(2):107-110. PubMed ID: 31986920
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fatty liver, alcoholic steatohepatitis, and non-alcoholic steatohepatitis].
    Bernal-Reyes R
    Rev Gastroenterol Mex; 2012 Aug; 77 Suppl 1():84-6. PubMed ID: 22939493
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence and associated factors to non-alcoholic steatohepatitis in obese patients subjected to bariatric surgery].
    Ferrer Márquez M; Rico Morales Mdel M; Carvia Pousaillè C; Gálvez Miras A; Casado Martín M; Velasco Albendea J; Ferrer Ayza M
    Cir Esp; 2008 Dec; 84(6):313-7. PubMed ID: 19087776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.
    De Ridder RJ; Schoon EJ; Smulders JF; van Hout GC; Stockbrügger RW; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():195-201. PubMed ID: 18081662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease: when to intervene and with what.
    Than NN; Newsome PN
    Clin Med (Lond); 2015 Apr; 15(2):186-90. PubMed ID: 25824073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
    Diehl AM; Day C
    N Engl J Med; 2017 Nov; 377(21):2063-2072. PubMed ID: 29166236
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis.
    Dixon JB
    Clin Liver Dis; 2007 Feb; 11(1):141-54, ix-x. PubMed ID: 17544976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric Surgery and Metabolic Dysfunction-Associated Fatty Liver Disease: a 2022 Update.
    Lazaridis II; Delko T
    Praxis (Bern 1994); 2023 Feb; 112(2):97-102. PubMed ID: 36722105
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management.
    Salomone F; Zelber-Sagi S; Galvano F; Fabbrini E
    Biomed Res Int; 2015; 2015():153276. PubMed ID: 26290862
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical management of obesity and the relationship to cardiovascular disease.
    Vest AR; Heneghan HM; Schauer PR; Young JB
    Circulation; 2013 Feb; 127(8):945-59. PubMed ID: 23439447
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver biopsy at the time of bariatric surgery: a benefit for patients and the medical community.
    Verna EC
    Semin Liver Dis; 2014 Feb; 34(1):1-6. PubMed ID: 24782252
    [No Abstract]   [Full Text] [Related]  

  • 20. [What is the position of bariatric surgery in the treatment of non-alcoholic steatohepatitis?].
    NtandjaWandji LC; Baud G; Lassailly G
    Presse Med; 2019 Dec; 48(12):1502-1506. PubMed ID: 31757736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.